亨通光電(600487.SH):子公司推出量產版400G QSFP-DD DR4硅光模塊
格隆匯3月25日丨亨通光電(600487.SH)公佈,公司的控股子公司亨通洛克利科技有限公司推出了量產版400G QSFP-DD DR4硅光模塊。
量產版400G QSFP-DD DR4硅光模塊使用英國洛克利小型化的硅光芯片和電芯片。該光模塊採用業界領先的7nmDSP芯片,產品的功耗低於9瓦,滿足節能減排綠色環保的數據中心應用的需求。模塊整體採用COB封裝方式,由於使用了獨特設計及工藝製造的硅光芯片,光纖和硅光芯片之間使用無源耦合,極大地減輕了製造難度,利於量產和降低製造成本。
公司將進一步加快推動400G QSFP-DD DR4硅光模塊的量產化工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.